Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$613,246
+$83,658 QoQ
Shares Held
2,437
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2,988
of 4,153 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Edgemoor Investment Advisors, Inc. holds $32,892,585 across 7 Drug Manufacturers - General names. ABBV ranks #6 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,032 | $13,232,112 | |
| 2 | NVS |
Novartis AG
|
52,824 | $8,278,577 | |
| 3 | PFE |
Pfizer Inc
|
292,257 | $7,037,548 | |
| 4 | JNJ |
Johnson & Johnson
|
10,588 | $2,689,034 | |
| 5 | AMGN |
Amgen Inc
|
1,910 | $691,649 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
2,437 | $613,246 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,727 | $350,419 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $613,246 | 2,437 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $529,588 | 2,435 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $555,916 | 2,433 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,066,704 | 4,607 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $451,056 | 2,430 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $485,876 | 2,319 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $411,908 | 2,318 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $418,065 | 2,117 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $368,939 | 2,151 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $391,332 | 2,149 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $304,825 | 1,967 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $333,745 | 2,239 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $301,391 | 2,237 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $356,191 | 2,235 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $377,359 | 2,335 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $338,746 | 2,524 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $443,245 | 2,894 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $432,347 | 2,667 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $335,250 | 2,476 | Shares | Sole | 2022-02-09 | |
| 2021-06-30 | $268,759 | 2,386 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $262,000 | 2,421 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $248,588 | 2,320 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $201,281 | 2,298 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||